ceruloplasmin fasting state
Selected indexed studies
- Laboratory Evaluation of Spasmodic Dysphonia. (J Voice, 2020) [PMID:31288958]
- Therapeutic Potential of Cinnamic Acid as an SGLT2 Inhibitor in Mitigating Diabetic Nephropathy in a Rat Model of Type 2 Diabetes. (Mol Nutr Food Res, 2025) [PMID:40574370]
- Association of serum trace elements with non-invasive fibrosis scores in metabolic dysfunction-associated steatotic liver disease. (Sci Rep, 2025) [PMID:40998881]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Therapeutic Potential of Cinnamic Acid as an SGLT2 Inhibitor in Mitigating Diabetic Nephropathy in a Rat Model of Type 2 Diabetes. (2025) pubmed
- Laboratory Evaluation of Spasmodic Dysphonia. (2020) pubmed
- Association of serum trace elements with non-invasive fibrosis scores in metabolic dysfunction-associated steatotic liver disease. (2025) pubmed
- Interplay of Postprandial Triglyceride-Rich Lipoprotein Composition and Adipokines in Obese Adolescents. (2024) pubmed
- Effects of Semaglutide and Empagliflozin on Inflammatory Markers in Patients with Type 2 Diabetes. (2023) pubmed
- Biochemical basis for the selection of oral contraceptives. (1978) pubmed
- Elevated serum ceruloplasmin levels in subjects with metabolic syndrome: a population-based study. (2002) pubmed
- Effects of multistrain probiotics on metabolic biomarkers, inflammation, and antioxidant system in patients with type 2 diabetes mellitus: a prospective controlled trial in Türkiye. (2026) pubmed
- Copper status and its relation to abdominal obesity indices and liver function in non-alcoholic fatty liver disease: a case-control study. (2024) pubmed
- Impact of Long-Term Cyclamate and Saccharin Consumption on Biochemical Parameters in Healthy Individuals and Type 2 Diabetes Mellitus Patients. (2023) pubmed